UC UC UC UC UC UC UC UC UC UC UC .../ DE000HR6EKB7 /
31/05/2024 21:45:23 | Diferencia+0.070 | Bid21:59:54 | Ask21:59:54 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
7.600EUR | +0.93% | 7.610 Volumen de oferta: 1,000 |
7.690 Tamaño/ Volumen/ Formato de Ask: 1,000 |
ESSILORLUXO. INH. EO... | 129.4719 EUR | 31/12/2078 | Call |
GlobeNewswire
1:00
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-li...
GlobeNewswire
02/06
Allergic diseases directly cost between 1,800 and 6,600 euros per patient per year
GlobeNewswire
02/06
Merus Presents Interim Data on MCLA-145 Monotherapy and in Combination with Pembrolizumab at the 202...
GlobeNewswire
02/06
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
GlobeNewswire
02/06
Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ’s Ear...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página